Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.

Afficher d'autres versions (1)

Détails bibliographiques
Auteurs principaux:	Hanekom, W, Dockrell, H, Ottenhoff, T, Doherty, T, Fletcher, H, Mcshane, H, Weichold, F, Hoft, D, Parida, S, Fruth, U
Format:	Journal article
Langue:	English
Publié:	2008

Documents similaires

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations
par: Hanekom, W, et autres
Publié: (2008)

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.
par: Willem A Hanekom, et autres
Publié: (2008-07-01)

A comparison of IFNgamma detection methods used in tuberculosis vaccine trials.
par: Beveridge, N, et autres
Publié: (2008)

Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?
par: Dockrell, HM, et autres
Publié: (2022)

Tuberculosis vaccines: current status and future prospects.
par: Fletcher, H, et autres
Publié: (2006)

Local pulmonary immunological biomarkers in tuberculosis
par: Morrison, H, et autres
Publié: (2021)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
par: Mcshane, H, et autres
Publié: (2016)

A New Vaccine for Tuberculosis: The Challenges of Development and Deployment
par: Fletcher, H, et autres
Publié: (2009)

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
par: Fletcher, H, et autres
Publié: (2013)

Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis.
par: Smith, S, et autres
Publié: (2009)

Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
par: Hazel M. Dockrell, et autres
Publié: (2022-05-01)

Vaccines for tuberculosis
par: McShane, H
Publié: (2013)

TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development
par: Kaufmann, S, et autres
Publié: (2017)

Tuberculosis vaccines
par: W. Hanekom
Publié: (2014-04-01)

Vaccine strategies against tuberculosis.
par: Mcshane, H
Publié: (2009)

Developing an improved vaccine against tuberculosis.
par: Mcshane, H
Publié: (2004)

Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG immunized adults vaccinated with a new tuberculosis vaccine, MVA85A (Clinical and Vaccine Immunology (2010) 17, 7, (1066-1073))
par: De Cassan, S, et autres
Publié: (2011)

Vaccine strategies against tuberculosis
par: H McShane
Publié: (2009-03-01)

Local Pulmonary Immunological Biomarkers in Tuberculosis
par: Hazel Morrison, et autres
Publié: (2021-03-01)

Th1/Th17 cell induction following vaccination with the novel tuberculosis vaccine MVA85A and their role in Mycobacterium tuberculosis challenge
par: Griffiths, K, et autres
Publié: (2011)

WHO preferred product characteristics for new vaccines against tuberculosis
par: Schrager, L, et autres
Publié: (2018)

Tuberculosis vaccines: present and future.
par: Minassian, A, et autres
Publié: (2008)

Tuberculosis vaccines in clinical trials.
par: Rowland, R, et autres
Publié: (2011)

Tuberculosis vaccines: progress and challenges.
par: Checkley, A, et autres
Publié: (2011)

Insights and challenges in tuberculosis vaccine development
par: McShane, H
Publié: (2019)

Tuberculosis vaccines: Progress and challenges
par: Checkley, A, et autres
Publié: (2011)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
par: McShane, H
Publié: (2011)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
par: McShane, H
Publié: (2011)

Tuberculosis vaccine promises sterilizing immunity.
par: Mcshane, H, et autres
Publié: (2011)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.
par: Hawkridge, T, et autres
Publié: (2008)

Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology
par: Stefan H. E. Kaufmann, et autres
Publié: (2020-02-01)

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
par: Mcshane, H, et autres
Publié: (2017)

Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function.
par: Dintwe, O, et autres
Publié: (2013)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
par: Griffiths, K, et autres
Publié: (2013)

Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.
par: Sander, C, et autres
Publié: (2007)

The future of vaccines for tuberculosis
par: Stockdale, L, et autres
Publié: (2019)

Improving tuberculosis vaccine trial efficiency: a tough nut to crack
par: McShane, H
Publié: (2023)

Clinical testing of tuberculosis vaccine candidates
par: Hatherill, M, et autres
Publié: (2016)

Why don’t we have an effective tuberculosis vaccine yet?
par: Davenne, T, et autres
Publié: (2016)

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
par: Mcshane, H, et autres
Publié: (2005)